Exelixis
EXEL
#1653
Rank
โ‚ฌ11.64 B
Marketcap
46,99ย โ‚ฌ
Share price
-1.47%
Change (1 day)
44.83%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Sustainability Reports

Thumbnail Exelixis Sustainability Report 2024

Sustainability Report 2024

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2022

Sustainability Report 2022

Language: English

View Sustainability Report